Philip Kantoff, MD, grew up in New York City, attended Brown University and its medical school, and did his internship/residency and chief residency in internal medicine at New York University Hospital/ Belleview Hospital in New York. He spent four years at the National Institutes of Health conducting research in gene therapy. He completed his medical oncology fellowship training at Dana-Farber Cancer Institute, Harvard Medical School, in 1987. Since then, he has been on the staff at the Dana-Farber Cancer Institute and Brigham & Women's Hospital. Dr. Kantoff is currently the director of The Lank Center for Genitourinary Oncology, and chief of the division of solid tumor oncology at the Dana-Farber Cancer Institute, Brigham & Women's Hospital. He is also the director of the prostate cancer program and NCI-sponsored SPORE in prostate cancer at the Dana-Farber Harvard Cancer Center. He is a professor of medicine at Harvard Medical School.
Dr. Kantoff has published more than 100 research articles on a variety of topics, including the molecular basis of genitourinary cancers and improved treatments for patients afflicted with prostate cancer, kidney cancer, bladder cancer, and testicular cancer. His laboratory research involves understanding the genetics of prostate cancer. His clinical research involves clinical trials of novel therapeutic treatments for the genitourinary cancers. He teaches at Harvard Medical School, and lectures internationally to both medical and lay audiences. Dr. Kantoff has written nearly 100 reviews and monographs on cancer and has edited numerous books, including Prostate Cancer, A Multi-Disciplinary Guide published by Blackwell, and Prostate Cancer: Principles and Practice, a definitive text on prostate cancer, published in December 2001 by Lippincott Williams & Wilkins. He has also written a popular book, Prostate Cancer, a Family Consultation, published by Houghton Mifflin. Dr. Kantoff is married to a physician, Rochelle Scheib, MD, and is the father of three children.